Aygestin and Humira drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aygestin (norethindrone acetate) and Humira (adalimumab). Common drug interactions include injection site haemorrhage among females.

The phase IV clinical study analyzes what interactions people have when they take Aygestin and Humira. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Aygestin?

Aygestin has active ingredients of norethindrone acetate. It is often used in endometriosis. eHealthMe is studying from 1,107 Aygestin users. Check the latest studies of Aygestin.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.



On Jul, 08, 2026

14 people who take Aygestin and Humira together, and have interactions are studied.

Aygestin and Humira drug interactions.

What are the common drug interactions of Aygestin and Humira, by gender? *:

female:

  1. Injection site haemorrhage (bleeding from injection site)
  2. Injection site pain
  3. Injection site rash
  4. Seasonal allergy (allergic condition due to certain season)
  5. Abdominal pain
  6. Abdominal pain upper
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  10. Cardiac disorder

male:

n/a

What are the common drug interactions of Aygestin and Humira, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Injection site pain

20-29:

  1. Injection site bruising
  2. Injection site haemorrhage (bleeding from injection site)
  3. Abdominal pain upper
  4. Chills (felling of cold)
  5. Dermatitis allergic (inflammation of the skin due allergic reaction)
  6. Headache (pain in head)
  7. Hidradenitis (chronic disease of a type of sweat gland)
  8. Injection site erythema (redness at injection site)
  9. Injection site pruritus (severe itching at injection site)
  10. Injection site urticaria (rash of round, red welts on the skin at injection site)

30-39:

  1. Urinary tract infection
  2. Injection site haemorrhage (bleeding from injection site)
  3. Injection site pain
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Seasonal allergy (allergic condition due to certain season)
  6. Abdominal pain
  7. Arthralgia (joint pain)
  8. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  9. Cardiac failure congestive

40-49:

  1. Asthenia (weakness)
  2. Cardiac disorder
  3. Chest pain
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Hepatic enzyme increased
  7. Intentional self-injury
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Procedural site reaction
  10. Rash

50-59:

  1. Asthma
  2. Candidiasis (candidiasis or thrush is a fungal infection)
  3. Sinusitis (inflammation of sinus)
  4. Vaginal discharge
  5. Cough
  6. Headache (pain in head)
  7. Injection site haematoma (localized swelling filled with blood at injection site)
  8. Injection site pain
  9. Injection site rash
  10. Oropharyngeal pain

60+:

n/a

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 35.71%
  2. Depression: 4 people, 28.57%
  3. Migraine (headache): 4 people, 28.57%
  4. High Blood Pressure: 3 people, 21.43%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
  6. Stress And Anxiety: 3 people, 21.43%
  7. Asthma: 3 people, 21.43%
  8. Pain: 3 people, 21.43%
  9. Birth Control: 3 people, 21.43%
  10. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Aygestin and Humira?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aygestin and Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aygestin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aygestin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humira and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on norethindrone acetate and adalimumab (the active ingredients of Aygestin and Humira, respectively), and Aygestin and Humira (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: